Related references
Note: Only part of the references are listed.A Practical Review of Proteasome Pharmacology
Tiffany A. Thibaudeau et al.
PHARMACOLOGICAL REVIEWS (2019)
Single-Cell Transcriptome Analysis Maps the Developmental Track of the Human Heart
Yueli Cui et al.
CELL REPORTS (2019)
Phosphomimetic-mediated in vitro rescue of hypertrophic cardiomyopathy linked to R58Q mutation in myosin regulatory light chain
Sunil Yadav et al.
FEBS JOURNAL (2019)
CADD: predicting the deleteriousness of variants throughout the human genome
Philipp Rentzsch et al.
NUCLEIC ACIDS RESEARCH (2019)
Evaluating the Clinical Validity of Hypertrophic Cardiomyopathy Genes
Jodie Ingles et al.
CIRCULATION-GENOMIC AND PRECISION MEDICINE (2019)
MYL2-associated congenital fiber-type disproportion and cardiomyopathy with variants in additional neuromuscular disease genes; the dilemma of panel testing
Minttu Marttila et al.
COLD SPRING HARBOR MOLECULAR CASE STUDIES (2019)
Genetic evaluation of cardiomyopathy: a clinical practice resource of the American College of Medical Genetics and Genomics (ACMG)
Ray E. Hershberger et al.
GENETICS IN MEDICINE (2018)
Navigating the nuances of clinical sequence variant interpretation in Mendelian disease
Natasha T. Strande et al.
GENETICS IN MEDICINE (2018)
Hypertrophic cardiomyopathy mutation R58Q in the myosin regulatory light chain perturbs thick filament-based regulation in cardiac muscle
Thomas Kampourakis et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2018)
Sarcomeric perturbations of myosin motors lead to dilated cardiomyopathy in genetically modified MYL2 mice
Chen-Ching Yuan et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
Mechanistic complexity of contractile dysfunction in hypertrophic cardiomyopathy
Michael Regnier
JOURNAL OF GENERAL PHYSIOLOGY (2018)
Identification of a novel hypertrophic cardiomyopathy-associated mutation using targeted next-generation sequencing
Yue Zhao et al.
INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE (2017)
Assessment of cardiac fibrosis: a morphometric method comparison for collagen quantification
Julia Schipke et al.
JOURNAL OF APPLIED PHYSIOLOGY (2017)
Multiple Gene Variants in Hypertrophic Cardiomyopathy in the Era of Next-Generation Sequencing
Charlotte Burns et al.
CIRCULATION-CARDIOVASCULAR GENETICS (2017)
Commentary: Next Generation Sequencing and Linkage Analysis for the Molecular Diagnosis of a Novel Overlapping Syndrome Characterized by Hypertrophic Cardiomyopathy and Typical Electrical Instability of Brugada Syndrome
Michelle M. Monasky et al.
FRONTIERS IN PHYSIOLOGY (2017)
Hypertrophic remodelling in cardiac regulatory myosin light chain (MYL2) founder mutation carriers
Godelieve R. F. Claes et al.
EUROPEAN HEART JOURNAL (2016)
Next Generation Sequencing and Linkage Analysis for the Molecular Diagnosis of a Novel Overlapping Syndrome Characterized by Hypertrophic Cardiomyopathy and Typical Electrical Instability of Brugada Syndrome
Ruggiero Mango et al.
CIRCULATION JOURNAL (2016)
Phosphorylation of the regulatory light chain of myosin in striated muscle: methodological perspectives
Haiyang Yu et al.
EUROPEAN BIOPHYSICS JOURNAL WITH BIOPHYSICS LETTERS (2016)
Myosin light chain phosphorylation enhances contraction of heart muscle via structural changes in both thick and thin filaments
Thomas Kampourakis et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
Molecular and Functional Effects of a Splice Site Mutation in the MYL2 Gene Associated with Cardioskeletal Myopathy and Early Cardiac Death in Infants
Zhiqun Zhou et al.
FRONTIERS IN PHYSIOLOGY (2016)
Targeted next-generation sequencing (NGS) of nine candidate genes with custom AmpliSeq in patients and a cardiomyopathy risk group
Andrey S. Glotov et al.
CLINICA CHIMICA ACTA (2015)
Novel familial dilated cardiomyopathy mutation in MYL2 affects the structure and function of myosin regulatory light chain
Wenrui Huang et al.
FEBS JOURNAL (2015)
Functions of myosin light chain-2 (MYL2) in cardiac muscle and disease
Farah Sheikh et al.
GENE (2015)
Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology
Sue Richards et al.
GENETICS IN MEDICINE (2015)
Churchill: an ultra-fast, deterministic, highly scalable and balanced parallelization strategy for the discovery of human genetic variation in clinical and population-scale genomics
Benjamin J. Kelly et al.
GENOME BIOLOGY (2015)
Evaluation of a new NGS method based on a custom AmpliSeq library and Ion Torrent PGM sequencing for the fast detection of genetic variations in cardiomyopathies
Gilles Millat et al.
CLINICA CHIMICA ACTA (2014)
Genetics and Disease of Ventricular Muscle
Diane Fatkin et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2014)
Regulatory Light Chain Mutants Linked to Heart Disease Modify the Cardiac Myosin Lever Arm
Thomas P. Burghardt et al.
BIOCHEMISTRY (2013)
Recessive MYL2 mutations cause infantile type I muscle fibre disease and cardiomyopathy
Marian A. J. Weterman et al.
BRAIN (2013)
Predicting the Functional, Molecular, and Phenotypic Consequences of Amino Acid Substitutions using Hidden Markov Models
Hashem A. Shihab et al.
HUMAN MUTATION (2013)
Genetic complexity in hypertrophic cardiomyopathy revealed by high-throughput sequencing
Luis R. Lopes et al.
JOURNAL OF MEDICAL GENETICS (2013)
Autosomal Recessive Transmission of MYBPC3 Mutation Results in Malignant Phenotype of Hypertrophic Cardiomyopathy
Yilu Wang et al.
PLOS ONE (2013)
High resolution melting: improvements in the genetic diagnosis of hypertrophic cardiomyopathy in a Portuguese cohort
Susana Santos et al.
BMC MEDICAL GENETICS (2012)
Myofilament Protein Gene Mutation Screening and Outcome of Patients With Hypertrophic Cardiomyopathy
Iacopo Olivotto et al.
MAYO CLINIC PROCEEDINGS (2012)
Identifying Sarcomere Gene Mutations in Hypertrophic Cardiomyopathy A Personal History
Christine E. Seidman et al.
CIRCULATION RESEARCH (2011)
Genetic basis of end-stage hypertrophic cardiomyopathy
Pablo Garcia-Pavia et al.
EUROPEAN JOURNAL OF HEART FAILURE (2011)
Identifying a High Fraction of the Human Genome to be under Selective Constraint Using GERP plus
Eugene V. Davydov et al.
PLOS COMPUTATIONAL BIOLOGY (2010)
Identifying novel constrained elements by exploiting biased substitution patterns
Manuel Garber et al.
BIOINFORMATICS (2009)
A new method for detection and quantification of heartbeat parameters in Drosophila, zebrafish, and embryonic mouse hearts
Martin Fink et al.
BIOTECHNIQUES (2009)
Simple and efficient site-directed mutagenesis using two single-primer reactions in parallel to generate mutants for protein structure-function studies
Oded Edelheit et al.
BMC BIOTECHNOLOGY (2009)
Sudden Deaths in Young Competitive Athletes Analysis of 1866 Deaths in the United States, 1980-2006
Barry J. Maron et al.
CIRCULATION (2009)
Diagnostic Yield, Interpretation, and Clinical Utility of Mutation Screening of Sarcomere Encoding Genes in Danish Hypertrophic Cardiomyopathy Patients and Relatives
Paal Skytt Andersen et al.
HUMAN MUTATION (2009)
Depletion of zebrafish essential and regulatory myosin light chains reduces cardiac function through distinct mechanisms
Zhenyue Chen et al.
CARDIOVASCULAR RESEARCH (2008)
Hypertrophic cardiomyopathy: the genetic determinants of clinical disease expression
Andre Keren et al.
NATURE CLINICAL PRACTICE CARDIOVASCULAR MEDICINE (2008)
Historical trends in reported survival rates in patients with hypertrophic cardiomyopathy
P. M. Elliott et al.
HEART (2006)
Molecular genetics in hypertrophic cardiomyopathy: towards individualized management of the disease
P Charron et al.
EXPERT REVIEW OF MOLECULAR DIAGNOSTICS (2006)
The E22K mutation of myosin RLC that causes familial hypertrophic cardiomyopathy increases calcium sensitivity of force and ATPase in transgenic mice
D Szczesna-Cordary et al.
JOURNAL OF CELL SCIENCE (2005)
Fine-tuning in Ca2+ homeostasis underlies progression of cardiomyopathy in myocytes derived from genetically modified embryonic stem cells
C Grey et al.
HUMAN MOLECULAR GENETICS (2005)
Phylogenetic estimation of context-dependent substitution rates by maximum likelihood
A Siepel et al.
MOLECULAR BIOLOGY AND EVOLUTION (2004)
Familial hypertrophic cardiomyopathy-linked alterations in Ca2+ binding of human cardiac myosin regulatory light chain affect cardiac muscle contraction
D Szczesna-Cordary et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Myosin binding protein C mutations and compound heterozygosity in hypertrophic cardiomyopathy
SL Van Driest et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2004)
Patterning of the cardiac outflow region in Drosophila
M Zikova et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Molecular mechanisms of inherited cardiomyopathies
D Fatkin et al.
PHYSIOLOGICAL REVIEWS (2002)
Human non-synonymous SNPs: server and survey
V Ramensky et al.
NUCLEIC ACIDS RESEARCH (2002)
Relation between myocyte disarray and outcome in hypertrophic cardiomyopathy
AM Varnava et al.
AMERICAN JOURNAL OF CARDIOLOGY (2001)
The molecular genetic basis for hypertrophic cardiomyopathy
AJ Marian et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2001)
Familial hypertrophic cardiomyopathy mutations in the regulatory light chains of myosin affect their structure, Ca2+ binding, and phosphorylation
D Szczesna et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
The genetic basis for cardiomyopathy: from mutation identification to mechanistic paradigms
JG Seidman et al.
CELL (2001)
Sudden death in hypertrophic cardiomyopathy: Identification of high risk patients
PM Elliott et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2000)
The effect of removing the N-terminal extension of the Drosophila myosin regulatory light chain upon flight ability and the contractile dynamics of the indirect flight muscle
JR Moore et al.
BIOPHYSICAL JOURNAL (2000)
Share Paper
